Clinical manifestations and pathogenesis of mitochondrial dysfunction in short stature.

IF 6.1 2区 医学 Q1 PEDIATRICS
World Journal of Pediatrics Pub Date : 2025-03-01 Epub Date: 2025-02-26 DOI:10.1007/s12519-025-00881-y
Yue Jiang, Zhi-Qiang Wan, Xin-Yue Zhang, Han-Ze Du, Yun-Meng Yang, Hui Pan, Yi Hu
{"title":"Clinical manifestations and pathogenesis of mitochondrial dysfunction in short stature.","authors":"Yue Jiang, Zhi-Qiang Wan, Xin-Yue Zhang, Han-Ze Du, Yun-Meng Yang, Hui Pan, Yi Hu","doi":"10.1007/s12519-025-00881-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mitochondria plays a pivotal role in cellular energy production, and their dysfunction can lead to a spectrum of mitochondrial diseases, affecting various organs with a wide range of clinical symptoms. Among these, short stature is a notable manifestation, yet its pathogenesis related to mitochondrial dysfunction remains underexplored.</p><p><strong>Data sources: </strong>A comprehensive literature search was conducted in the PubMed, Medline, and EMBASE databases from inception to November 2024. Patient demographics, genetic confirmation type, clinical features associated with short stature or growth abnormalities, and any interventions or treatments alongside treatment outcomes were extracted.</p><p><strong>Results: </strong>Our article provides a comprehensive review of the clinical manifestations and delves into the molecular mechanisms of mitochondrial dysfunction that are associated with short stature. A total of 134 genetically confirmed cases with primary mitochondrial disease (PMD) associated with short stature with mtDNA (e.g., m.3243A>G, large-scale deletions) and nDNA mutations (e.g., NDUFB3, SURF1). Median age at short stature detection was 8 years, with 40% presenting earlier. Growth hormone deficiency (GHD) occurred in 15% of cases, showing variable responses to therapy. Pathogenesis involves mitochondrial dysfunction, growth plate impairment, and endocrine disorders. Early diagnosis relies on timely genetic testing. Management of PMD includes tailored dietary strategies, supplementation, and cautious GH therapy due to potential risks. Emerging gene therapy and multidisciplinary care are emphasized to address disease complexity and optimize outcomes.</p><p><strong>Conclusions: </strong>Previous reviews have described the endocrine aspects of mitochondrial diseases. Although the list of endocrine diseases is comprehensive, it is not specific for short stature. This review focuses on short stature, and it is more specific than previous reviews in terms of etiology, pathogenesis, diagnosis, treatment, and prospects.</p>","PeriodicalId":23883,"journal":{"name":"World Journal of Pediatrics","volume":" ","pages":"223-251"},"PeriodicalIF":6.1000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Pediatrics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12519-025-00881-y","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/26 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Mitochondria plays a pivotal role in cellular energy production, and their dysfunction can lead to a spectrum of mitochondrial diseases, affecting various organs with a wide range of clinical symptoms. Among these, short stature is a notable manifestation, yet its pathogenesis related to mitochondrial dysfunction remains underexplored.

Data sources: A comprehensive literature search was conducted in the PubMed, Medline, and EMBASE databases from inception to November 2024. Patient demographics, genetic confirmation type, clinical features associated with short stature or growth abnormalities, and any interventions or treatments alongside treatment outcomes were extracted.

Results: Our article provides a comprehensive review of the clinical manifestations and delves into the molecular mechanisms of mitochondrial dysfunction that are associated with short stature. A total of 134 genetically confirmed cases with primary mitochondrial disease (PMD) associated with short stature with mtDNA (e.g., m.3243A>G, large-scale deletions) and nDNA mutations (e.g., NDUFB3, SURF1). Median age at short stature detection was 8 years, with 40% presenting earlier. Growth hormone deficiency (GHD) occurred in 15% of cases, showing variable responses to therapy. Pathogenesis involves mitochondrial dysfunction, growth plate impairment, and endocrine disorders. Early diagnosis relies on timely genetic testing. Management of PMD includes tailored dietary strategies, supplementation, and cautious GH therapy due to potential risks. Emerging gene therapy and multidisciplinary care are emphasized to address disease complexity and optimize outcomes.

Conclusions: Previous reviews have described the endocrine aspects of mitochondrial diseases. Although the list of endocrine diseases is comprehensive, it is not specific for short stature. This review focuses on short stature, and it is more specific than previous reviews in terms of etiology, pathogenesis, diagnosis, treatment, and prospects.

矮个子患者线粒体功能障碍的临床表现及发病机制。
背景:线粒体在细胞能量产生中起着关键作用,其功能障碍可导致一系列线粒体疾病,影响各种器官并伴有广泛的临床症状。其中,身材矮小是一个值得注意的表现,但其与线粒体功能障碍相关的发病机制尚不清楚。数据来源:在PubMed, Medline和EMBASE数据库中进行了全面的文献检索,从成立到2024年11月。提取患者人口统计学、基因确认类型、与矮小身材或生长异常相关的临床特征以及任何干预措施或治疗方法以及治疗结果。结果:本文综述了与矮小相关的线粒体功能障碍的临床表现,并探讨了线粒体功能障碍的分子机制。共有134例遗传确诊的原发性线粒体疾病(PMD)与身材矮小、mtDNA(例如,m.3243A>G,大规模缺失)和nDNA突变(例如,NDUFB3, SURF1)相关。发现身材矮小的中位年龄为8岁,40%的患者更早出现。生长激素缺乏症(GHD)发生在15%的病例中,对治疗的反应不同。发病机制包括线粒体功能障碍、生长板损伤和内分泌紊乱。早期诊断依赖于及时的基因检测。PMD的管理包括量身定制的饮食策略,补充和谨慎的生长激素治疗,因为潜在的风险。新兴的基因治疗和多学科护理强调解决疾病的复杂性和优化的结果。结论:以前的综述已经描述了线粒体疾病的内分泌方面。虽然内分泌疾病的清单是全面的,但它并不是针对身材矮小的。本文以矮小为重点,在病因、发病机制、诊断、治疗和前景等方面比以往的综述更具体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World Journal of Pediatrics
World Journal of Pediatrics 医学-小儿科
CiteScore
10.50
自引率
1.10%
发文量
592
审稿时长
2.5 months
期刊介绍: The World Journal of Pediatrics, a monthly publication, is dedicated to disseminating peer-reviewed original papers, reviews, and special reports focusing on clinical practice and research in pediatrics. We welcome contributions from pediatricians worldwide on new developments across all areas of pediatrics, including pediatric surgery, preventive healthcare, pharmacology, stomatology, and biomedicine. The journal also covers basic sciences and experimental work, serving as a comprehensive academic platform for the international exchange of medical findings.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信